Chromanol 293B
SIGMA/C2615 - ≥98% (HPLC), powder
Synonym: trans-
CAS Number: 163163-23-3
Empirical Formula (Hill Notation): C15H20N2O4S
Molecular Weight: 324.40
MDL Number: MFCD06798368
Linear Formula: C15H20N2O4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C15H20N2O4S/c1-5-22(19 |
| InChI key | HVSJHHXUORMCGK-UONOGXRCSA |
| Quality Level | 100 ![]() |
| SMILES string | CCS(=O)(=O)N(C)[C@@H]1[C@ |
| solubility | DMSO: 18 mg/mL |
| storage temp. | −20°C |
| Application: | Chromanol 293B has been used in the inhibition of calcium and cyclic adenosine monophosphate (cAMP)-activated potassium channels in human epithelial cell lines. Chromanol 293B has been used in patch-clamp electrophysiology studies in cardiomyocytes. |
| Biochem/physiol Actions: | Blocker of the slow delayed rectifier K+ current via KCNQ1 channels |
| Features and Benefits: | This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: | Chromanol 293B enantiomer is a potent inhibitor of potassium channel protein (KvLQT1). In human atrial myocytes, chromanol 293B inhibits repolarization potassium currents. Chromanol 293B improves glucose-stimulated insulin secretion (GSIS) in pancreas by modulating potassium voltage-gated channel (KCNQ1). |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H312 - H332 |
| Precautionary statements | P280 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 7/9-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


